Navigation Links
SuperGen's PIM Kinase Inhibitor, SGI-1776, Causes Tumor Regression in AML Xenograft Models
Date:6/13/2008

later this year. SGI-1776 may become the first drug in this class of inhibitors to enter the clinic."

SuperGen's schedule of presentations at EHA is as follows:

Date Time (PDT) Abstract # and Title

Friday, June 13 8:45 a.m.-10 a.m. #744 - A potent small molecule PIM

kinase inhibitor with in vivo oral

availability and activity in cell

lines from hematological

malignancies

Sunday, June 15 1:30 a.m.-2:45 a.m. #741 - SGI-1252: A potent small

Oral Presentation molecule JAK2 inhibitor

Hall C5

About SuperGen

Based in Dublin, Calif., SuperGen, Inc. is a pharmaceutical company dedicated to the discovery, rapid development and commercialization of therapies for solid tumors and hematological malignancies. SuperGen is developing a number of therapeutic anticancer products focused on kinase and cell signaling inhibitors and DNA methyltransferase inhibitors. For more information about SuperGen, please visit http://www.supergen.com.

Forward-Looking Statements

This news release contains certain "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are typically preceded by words such as "believes," "expects," "anticipates," "intends," "will," "may," "should," or similar expressions. These forward-looking statements are not guarantees of future performance and involve a number of risks and uncertainties that may cause actual results to differ materially from the results discussed in these statements. Factors that might cause the company's results to differ materially from those expressed or implied by such forward-looking
'/>"/>

SOURCE SuperGen Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Telik Announces Presentation of Preclinical Data on Dual Inhibitors of Aurora Kinases and VEGFR2
2. Telik Announces Preclinical Data Demonstrating Anti-Cancer Activity of Dual Inhibitors of Aurora Kinase and VEGFR2
3. Semafores PI3 Kinase Inhibitor SF1126 is Active Against Tumor and Tumor Cells and Synergizes with Standard Chemotherapy Agents
4. SuperGen Reports Initiation of Multi-arm Phase 1b Trial of Novel Tyrosine Kinase Inhibitor
5. EntreMed to Highlight ENMD-2076 Kinase Inhibitor at 2008 AACR Annual Meeting
6. Semafores PI3 Kinase Inhibitor SF1126 is a Vascular Targeted Conjugate in Phase I Clinical Trials in Solid Tumors and Multiple Myeloma
7. Ardea Biosciences Presents Data Demonstrating Favorable Pharmacokinetics and Efficacy for Mitogen-Activated ERK Kinase (MEK) Inhibitors
8. SuperGen Identifies Lead PIM Kinase Inhibitor, SGI-1776, That Causes Tumor Regression in AML Xenograft Models
9. Latest Cell Publication Describes the Novel Kinase Regulators Using OriGenes Functional Kinome Collection
10. Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute
11. Kosan Opens Registration Program for Lead Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... , July 28, 2015   Regulus Therapeutics ... leading the discovery and development of innovative medicines targeting ... and highlights for the quarter ended June 30, 2015 ... markets close. Regulus will host a ... at 5:00 pm Eastern Daylight Time to discuss its ...
(Date:7/28/2015)... 2015  Psychemedics Corporation (NASDAQ: PMD ) today ... June 30, 2015.  The Company also announced a quarterly ... record as of August 7, 2015 to be paid ... 76 th consecutive quarterly dividend. The ... was $7.0 million versus $7.7 million for the quarter ...
(Date:7/28/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/cng4gn/refurbished ) ... Equipment Market - Global Forecasts to 2019" report ... equipment market is estimated to grow expected to reach ... from 2014 to 2019. Factors ... to financial constraints, increasing privatization in the healthcare sector, ...
Breaking Medicine Technology:Regulus Announces Timing for Second Quarter 2015 Financial Results Webcast and Conference Call 2Regulus Announces Timing for Second Quarter 2015 Financial Results Webcast and Conference Call 3Psychemedics Corporation Announces Second Quarter Earnings 2Psychemedics Corporation Announces Second Quarter Earnings 3Psychemedics Corporation Announces Second Quarter Earnings 4Psychemedics Corporation Announces Second Quarter Earnings 5Psychemedics Corporation Announces Second Quarter Earnings 6Psychemedics Corporation Announces Second Quarter Earnings 7Psychemedics Corporation Announces Second Quarter Earnings 8Refurbished Medical Equipment Market 2015 - Global Forecasts to 2019 2
... Pepex Biomedical, Inc. has unveiled development of a ... will combine regular glucose monitoring and insulin delivery ... a complete product line of multi-function meters which ... insulin delivery, appropriate to each glucose level measurement, ...
... 2010 URAC, a leading health ... to three products within its suite of Pharmacy ... are part of URAC,s commitment to regular comprehensive ... http://photos.prnewswire.com/prnh/20100422/URACLOGO ) These are the ...
Cached Medicine Technology:Pepex™ Unveils Development of First All-In-One Blood Glucose Meter 2URAC Releases Revised Standards in Three of Its Industry-Leading Pharmacy Quality Management® Accreditation Programs 2URAC Releases Revised Standards in Three of Its Industry-Leading Pharmacy Quality Management® Accreditation Programs 3URAC Releases Revised Standards in Three of Its Industry-Leading Pharmacy Quality Management® Accreditation Programs 4
(Date:7/28/2015)... ... July 29, 2015 , ... The insurance telematics or usage-based insurance (UBI) industry ... to access the on-board vehicle data and better understand customer behavior behind the wheel. ... vehicle data. However times are changing and automakers realize that with the Internet of ...
(Date:7/28/2015)... ... 2015 , ... Santa Rosa’s The Press Democrat announced its annual report of the very best ... Dr. Heather Furnas took the top spot as the Best Cosmetic Surgeons in Sonoma ... proud to be bestowed such a prestigious title. , The Press Democrat was ...
(Date:7/28/2015)... FL (PRWEB) , ... July 28, 2015 , ... ... and The Miriam Hospital examines outcomes for inmates who continued methadone maintenance treatment ... latter group was more likely to relapse to opiate use (1) and more ...
(Date:7/28/2015)... ... ... Morristown Medical Center, part of Atlantic Health System, today announced it was ... the nation, to implant the newly approved CoreValve® Evolut® R System from Medtronic. The ... condition. , The CoreValve® Evolut® R System was approved by the U.S. Food and ...
(Date:7/28/2015)... ... July 28, 2015 , ... Healthline , a provider of intelligent ... (1) examining consumers’ perspectives on digital health . The survey, which was conducted ... innovations in digital health, level of trust in the security of digital health tools, ...
Breaking Medicine News(10 mins):Health News:General Motors Engaging Insurance Partners for the Connected Car 2Health News:General Motors Engaging Insurance Partners for the Connected Car 3Health News:Dr. Canales and Dr. Furnas Honored as Sonoma County’s Best Cosmetic Surgeons 2Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 2Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 3Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 4Health News:Morristown Medical Center First Hospital in New Jersey to Implant Newly Approved Heart Valve 2Health News:Morristown Medical Center First Hospital in New Jersey to Implant Newly Approved Heart Valve 3Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 2Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 3Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 4Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 5
... undergoing a radical prostatectomy can greatly increase their chances ... Henry Ford Hospital. , Results from the study done ... procedure improves the 5-, 10-, 15- and 20-year survival ... such as radiotherapy or watchful waiting. , "When given ...
... Menarini Group chooses Enterprise Quality Management Solution to ... 11 Sparta Systems, Inc., the maker of ... quality and compliance management, today announced that Menarini ... selected its TrackWise Enterprise Quality Management System ...
... May 11 Blue Cross Blue Shield of Michigan today ... ability to purchase coverage for autism treatment programs that ... covers children aged two to five years old who ... new benefit option is subject to approval by the ...
... KIBBUTZ SHAMIR, Israel, May 11 Shamir Optical Industry ... ") a leading provider of innovative products and technology ... Company received a letter on May 7, 2009 from ... does not meet the independent director and audit committee ...
... On May 19th, The EntreTech Forum will bring together some of ... nexus of innovation, and to answer key questions around:, ... local resource base for photonics-based innovation , ... for early-stage research-driven photonics entrepreneurs , ...
... opportunities to identify heart disease before patients start displaying ... in the May issue of UK-based IJCP, the ... Oregon, Maryland and Delaware, USA, found that just over ... disease. However, only 19% of those individuals - who ...
Cached Medicine News:Health News:Surgery improves survival for prostate cancer patients younger than 50 2Health News:Leading Italian Pharmaceutical Group Deploys TrackWise(R) Solution to Improve Quality Processes 2Health News:Leading Italian Pharmaceutical Group Deploys TrackWise(R) Solution to Improve Quality Processes 3Health News:Blue Cross Blue Shield of Michigan Plans to Offer Customer Groups Ability to Purchase Coverage of Autism Treatment Programs that Provide Intensive Early Intervention 2Health News:Shamir Optical Industry Ltd. Announces Receipt of Notice from Nasdaq of Failure to Satisfy Continued Listing Requirements 2Health News:Shamir Optical Industry Ltd. Announces Receipt of Notice from Nasdaq of Failure to Satisfy Continued Listing Requirements 3Health News:The EntreTech Forum Presents ... PHOTONICS/OPTICS - Understanding the Latest Applications of Light-based Technologies in Medical, Consumer, Industrial, and Defense Sectors 2Health News:The EntreTech Forum Presents ... PHOTONICS/OPTICS - Understanding the Latest Applications of Light-based Technologies in Medical, Consumer, Industrial, and Defense Sectors 3Health News:Less than 1 in 5 heart problems are diagnosed before symptoms appear 2Health News:Less than 1 in 5 heart problems are diagnosed before symptoms appear 3
... Ultrapure MB Grade PRODUCT SPECIFICATIONS Form: Granular, free flowing ... to 0.12 Gel Point (3%): less than or ... or equal to 76C Gel Strength (3%): greater than ... (5%): greater than or equal to 1000 gm/cm 2 ...
... Ultrapure MB Grade PRODUCT SPECIFICATIONS Form: Granular, free-flowing ... to 0.12 Gel Point (3%): less than or ... or equal to 80C Gel Strength (1.5%): greater ... Gel Strength (3%): greater than or equal to ...
... ≤ 5000 mg/kg sulfate (SO 4 ) ≤ 5000 ... 5 mg/kg Co ≤ 5 mg/kg Cr ≤ 5 ... K ≤ 50 mg/kg Mg ≤ 5 mg/kg Mn ... 5 mg/kg Pb ≤ 5 mg/kg Zn ≤ 5 ...
... (Cl) ≤ 500 mg/kg sulfate (SO 4 ) ≤ ... ≤ 5 mg/kg Co ≤ 5 mg/kg Cr ≤ ... mg/kg K ≤ 5 mg/kg Mg ≤ 5 mg/kg ... ≤ 5 mg/kg Pb ≤ 5 mg/kg Zn ≤ ...
Medicine Products: